Impact of prenatal screening on the birth status of fetuses with Down syndrome at an urban hospital, 1972-1994

Genetics in Medicine - Tập 1 - Trang 22-28 - 1998
Tamsen M. Caruso1, Marie-Noel Westgate1, Lewis B. Holmes1
1From the Department of Newborn Medicine, Brigham and Women’s Hospital; Genetics and Teratology Unit, Pediatric Service, Massachusetts General Hospital; and Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.

Tài liệu tham khảo

Ferguson-Smith, 1984, Maternal age-specific rates for chromosomal aberrations and factors influencing them: Report of a collaborative study on 52,965 amniocenteses, Prenat Diagn, 4, 5, 10.1002/pd.1970040704 Hook, 1984, The frequency of 47, 21, 47, + 18, and 47, +13 at the upper-most extremes of maternal ages: Results on 56,094 fetuses studied prenatally and comparison with data on livebirths, Hum Genet, 68, 211, 10.1007/BF00418391 DiMaio, 1987, Screening for fetal Down’s syndrome in pregnancy by measuring maternal serum alpha-fetoprotein levels, N Engl J Med, 317, 342, 10.1056/NEJM198708063170603 Benacerraf, 1987, Sonographic identification of second-trimester fetuses with Down’s syndrome, N Engl J Med, 317, 1371, 10.1056/NEJM198711263172203 Hook, 1989, Am J Hum Genet, 45, 855 Snijders, 1994, Maternal age-specific risks for trisomies at 9-14 weeks’ gestation, Prenat Diag, 14, 543, 10.1002/pd.1970140706 Nelson, 1989, Malformations due to presumed spontaneous mutations in newborn infants, N Engl J Med, 320, 19, 10.1056/NEJM198901053200104 Lieberman, 1987, Medical and socioeconomic characteristics accounting for racial differences in the rates of premature births, N Engl J Med, 33, 3 Department of Obstetrics and Gynecology. Annual reports, 1983 to 1994, from the Department of Obstetrics and Gynecology, Brigham and Women’s Hospital, Boston, MA Benacerraf, 1988, Early amniocentesis for prenatal cytogenetic evaluation, Radiology, 169, 709, 10.1148/radiology.169.3.3055033 Merkatz, 1984, An association between low maternal serum alpha-fetoprotein and fetal chromosome abnormalities, Am J Obstet Gynecol, 148, 886, 10.1016/0002-9378(84)90530-1 Goodbum, 1994, Second trimester maternal screening using alpha-fetoprotein, human chorionic gonadotrophin and unconjugated oestriol: Experience of a regional program, Prenat Diag, 14, 391, 10.1002/pd.1970140509 Wu, 1986, Maternal serum α-fetoprotein screening and Down’s syndrome, Am J Obstet Gynecol, 155, 1362, 10.1016/0002-9378(86)90183-3 Haddow, 1992, Prenatal screening for Down’s syndrome with use of maternal serum markers, N Engl J Med, 327, 588, 10.1056/NEJM199208273270902 Benson, 1989, Doppler demonstration of reversed umbilical blood flow in an acar- diac twin, J Clin Ultrasound, 17, 291, 10.1002/jcu.1870170412 Vincent, 1991, Pregnancy termination because of chromosomal abnormalities: A study of 26,950 amniocenteses in the southeast, South Med J, 84, 1210, 10.1097/00007611-199110000-00012 Alberman, 1995, Down’s syndrome births and pregnancy terminations in 1989 to 1993: Preliminary findings, Br J Obstet Gynaecol, 102, 445, 10.1111/j.1471-0528.1995.tb11315.x Limb, 1994, Anencephaly: Changes in prenatal detection and birth status, 1972 through 1990, Am J Obstet Gynecol, 170, 1333, 10.1016/S0002-9378(13)90460-9 Brower, 1993, Trends in neural tube defects 1980-1989, Med J Aust, 158, 152, 10.5694/j.1326-5377.1993.tb121690.x Sharland, 1997, Changing impact of fetal diagnosis of congenital heart disease, Arch Dis Child Fetal Neonatal Ed, 77, F1, 10.1136/fn.77.1.F1 Olsen, 1996, The effects of prenatal diagnosis, population ageing, and changing fertility rates on the live birth prevalence of Down syndrome in New York State, 1983-1992, Prenat Diagn, 16, 991, 10.1002/(SICI)1097-0223(199611)16:11<991::AID-PD977>3.0.CO;2-5 Stoll, 1994, Recent trends in the prevalence of Down syndrome in north-eastern France, Ann Genet, 37, 179 Anderman, 1995, Down’s syndrome births and pregnancy terminations in 1989 to 1993: Preliminary findings, Br. J Obstet Gynaecol, 102, 445, 10.1111/j.1471-0528.1995.tb11315.x Hook, 1982, Contribution of chromosome abnormalities to human morbidity and mortality, Cytogenet Cell Genet, 33, 101, 10.1159/000131733 Baird, 1988, Maternal age-specific rates for Down syndrome: Changes over time, Am J Med Genet, 29, 917, 10.1002/ajmg.1320290424 Walker, 1986, Cytogenetic prenatal diagnosis and its relative effectiveness in the Mersey region and North Wales, Prenat Diagn, 6, 13, 10.1002/pd.1970060103 Mikkelson, 1988, The incidence of Down’s syndrome and progress towards its reduction, Philos Trans R Soc Lond B Biol Sei, 319, 315, 10.1098/rstb.1988.0053 Priest, 1988, Prenatal diagnosis in metropolitan Atlanta and the impact on autosomal trisomies, Am J Obstet Gynecol, 159, 1306, 10.1016/0002-9378(88)90472-3 Palomaki, 1996, Prenatal screening for Down’s syndrome in Maine, 1980 to 1993, NEngl J Med, 334, 1409, 10.1056/NEJM199605233342117